# A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis

> **NCT00046072** · PHASE2 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 300 (—)

## Conditions studied

- Sepsis
- Shock, Septic
- Sepsis Syndrome
- Septicemia
- Infection

## Interventions

- **DRUG:** E5564

## Key facts

- **NCT ID:** NCT00046072
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 300 (—)
- **Last updated:** 2005-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046072, "A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00046072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*